Correction to: Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer (Molecular Cancer, (2019), 18, 1, (3), 10.1186/s12943-018-0931-9)

2Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Following the publication of the original paper [1], the authors realized that there are errors in Fig. 3d and Fig. 6e, which caused duplications. The errors occurred during the preparation of figures and went unnoticed during the review process and during preparation of final publication. The revised Figures are shown below. This correction does not alter any of the findings or conclusions of the study. The authors regret this error. The specific changes of figures are listed as follows: 1. Figure 3d (Replacement for 48h of SKBR-3TR cells), 2. Figure 6e (Replacement for 0h (sh-TINCR#1+p- Snail-1) of SKBR-3TR cells) (insert figures here) (Figure presented.).

Cite

CITATION STYLE

APA

Dong, H., Hu, J., Zou, K., Ye, M., Chen, Y., Wu, C., … Han, M. (2021, December 1). Correction to: Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer (Molecular Cancer, (2019), 18, 1, (3), 10.1186/s12943-018-0931-9). Molecular Cancer. BioMed Central Ltd. https://doi.org/10.1186/s12943-021-01385-9

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free